All Stories

  1. “Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line”
  2. Molecular Pathways in Childhood Acute Lymphoblastic Leukemia: From the Bench to the Bedside